◀ Back to IL2
IL2 — PGP
Text-mined interactions from Literome
Mu et al., J Clin Immunol 1999
:
Thus, human T cells do not markedly up-regulate their expression of functional Pgp molecules as detected by mAb 4E3 following activation, suggesting that
Pgp does not
play a major role in
IL-2 secretion by activated T cells
Gollapudi et al., Genes Immun 2000
:
These data show that
P-gp is not
required for secretion of
IL-2 , IFN-gamma, IL-4, and IL-10 secretion in mice and IL-2 secretion in humans
Bonhomme-Faivre et al., Anticancer Drugs 2002
:
Based on the premise that Taxol pharmacokinetic parameters could be modified as a result of diminished
P-gp expression
induced by recombinant
interleukin ( rIL ) -2 and that this might elicit an interaction between the two drugs, we evaluated the pharmacokinetics of a novel strategy combining i.p. immunotherapy with rIL-2 and a cytotoxic agent, Taxol
Bonhomme-Faivre et al., Int J Pharm 2002
(Body Weight) :
Inhibitors of
P-glycoprotein (P-gp) ( verapamil ) or cytochrome P-450 ( ketoconazole ) may
reduce IL2 production and T lymphocyte proliferation in vitro
Belliard et al., J Pharm Pharmacol 2002
:
Caco-2 cells were used to investigate the
effect of human recombinant
interleukin-2 (IL2) on intestinal
P-glycoprotein (P-gp) transporter activity in-vitro ... The inhibitory
effect of
IL2 on
P-gp activity was found to be independent of tight junction function as demonstrated by constant transepithelial electrical resistance ( TEER ) measurements for all experimental conditions encountered in this study ( time and concentration of IL2 exposure )
Pawlik et al., J Pharm Pharmacol 2005
:
P-gp inhibitors
suppressed the release of
IL-2 , IL-4, IFN-gamma and TNF-alpha from PHA stimulated MNC, whereas release of IL-6 and IL-10 remained unaffected